This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
November 9, 2016: A $1.2 million research grant is helping scientists get one step closer to eliminating liver cancer. Made possible by Canadian Liver Foundation (CLF) and an anonymous donor via the Toronto General & Western Hospital Foundation (TG&WHF), this research will explore how nanoparticles can support the body’s immune system kill liver cancer cells.
Dr. Ian McGilvray, liver transplant and cancer surgeon and Senior Scientist at Toronto General Research Institute, University Health Network, is leading the initiative. Dr. McGilvray and a multidisciplinary team of investigators will explore how nanoparticles can target and destroy immune cells that help liver cancer evade detection and grow.
“This research will bring us one step closer to conquering this deadly disease,” says Dr. McGilvray. “We are, quite literally, on a mission to cure liver cancer by harnessing the power of the immune system.”
Read complete press release here: http://www.liver.ca/newsroom/press-releases/11-09-2016_CLF_UHN_liver_cancer_grant.aspx